192 related articles for article (PubMed ID: 2359685)
1. Succinylacetone and delta-aminolevulinic acid dehydratase in hereditary tyrosinemia: immunochemical study of the enzyme.
Sassa S; Fujita H; Kappas A
Pediatrics; 1990 Jul; 86(1):84-6. PubMed ID: 2359685
[TBL] [Abstract][Full Text] [Related]
2. Succinylacetone inhibits delta-aminolevulinate dehydratase and potentiates the drug and steroid induction of delta-aminolevulinate synthase in liver.
Sassa S; Kappas A
Trans Assoc Am Physicians; 1982; 95():42-52. PubMed ID: 7182986
[TBL] [Abstract][Full Text] [Related]
3. Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone.
Sassa S; Kappas A
J Clin Invest; 1983 Mar; 71(3):625-34. PubMed ID: 6826727
[TBL] [Abstract][Full Text] [Related]
4. Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia.
Grenier A; Lescault A; Laberge C; Gagné R; Mamer O
Clin Chim Acta; 1982 Aug; 123(1-2):93-9. PubMed ID: 7116642
[TBL] [Abstract][Full Text] [Related]
5. ["Succinylacetone effect' after oral homogentisate loading].
Laberge C; Lescault A; Grenier A; Gagné R
Union Med Can; 1981 Jul; 110(7):621-5. PubMed ID: 7292795
[No Abstract] [Full Text] [Related]
6. On the enzymic defects in hereditary tyrosinemia.
Lindblad B; Lindstedt S; Steen G
Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4641-5. PubMed ID: 270706
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic defect in a child with hereditary hepatic porphyria due to homozygous delta-aminolevulinic acid dehydratase deficiency: immunochemical studies.
Fujita H; Sassa S; Lundgren J; Holmberg L; Thunell S; Kappas A
Pediatrics; 1987 Dec; 80(6):880-5. PubMed ID: 3684400
[TBL] [Abstract][Full Text] [Related]
8. Biochemical studies on the enzymatic deficiencies in hereditary tyrosinemia.
Berger R; van Faassen H; Smith GP
Clin Chim Acta; 1983 Oct; 134(1-2):129-41. PubMed ID: 6652907
[TBL] [Abstract][Full Text] [Related]
9. [Surgical and metabolic aspects of liver transplantation for tyrosinemia].
Bruneau N; St-Vil D; Luks FI; LaBerge JM; Bensoussan AL; Blanchard H
Ann Chir; 1993; 47(9):803-9. PubMed ID: 8141543
[TBL] [Abstract][Full Text] [Related]
10. Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: study of three patients after liver transplantation.
Tuchman M; Freese DK; Sharp HL; Ramnaraine ML; Ascher N; Bloomer JR
J Pediatr; 1987 Mar; 110(3):399-403. PubMed ID: 3546650
[TBL] [Abstract][Full Text] [Related]
11. Rapid improvement in the renal tubular dysfunction associated with tyrosinemia following hepatic replacement.
Shoemaker LR; Strife CF; Balistreri WF; Ryckman FC
Pediatrics; 1992 Feb; 89(2):251-5. PubMed ID: 1734392
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of succinylacetone and delta-aminolevulinic acid in patients with hereditary tyrosinemia.
Christensen E; Jacobsen BB; Gregersen N; Hjeds H; Pedersen JB; Brandt NJ; Baekmark UB
Clin Chim Acta; 1981 Nov; 116(3):331-41. PubMed ID: 7296896
[TBL] [Abstract][Full Text] [Related]
13. Alteration of activities of delta-aminolevulinic acid synthase, delta-aminolevulinic acid dehydratase and delta-aminolevulinic acid dehydratase inhibitor in the bone marrow cells of lead poisoned rats.
Kondo M; Kajimoto M; Urata G
Exp Hematol; 1983 Apr; 11(4):324-31. PubMed ID: 6840227
[TBL] [Abstract][Full Text] [Related]
14. Tyrosinemia: the Quebec experience.
Paradis K
Clin Invest Med; 1996 Oct; 19(5):311-6. PubMed ID: 8889268
[TBL] [Abstract][Full Text] [Related]
15. The pre- and post-natal diagnosis of tyrosinemia type I and the detection of the carrier state by assay of fumarylacetoacetase.
Kvittingen EA; Brodtkorb E
Scand J Clin Lab Invest Suppl; 1986; 184():35-40. PubMed ID: 3473612
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of succinylacetone after homogentisate and tyrosine loading in healthy individuals with low fumarylacetoacetase activity.
Kvittingen EA; Leonard JV; Pettit BR; King GS
Clin Chim Acta; 1985 Nov; 152(3):271-9. PubMed ID: 4064334
[TBL] [Abstract][Full Text] [Related]
17. Induction of delta-aminolevulinic acid dehydratase in mouse Friend virus-transformed erythroleukemia cells during erythroid differentiation.
Chang CS; Sassa S
Blood; 1984 Jul; 64(1):64-70. PubMed ID: 6587918
[TBL] [Abstract][Full Text] [Related]
18. Hereditary tyrosinemia. Formation of succinylacetone-amino acid adducts.
Manabe S; Sassa S; Kappas A
J Exp Med; 1985 Sep; 162(3):1060-74. PubMed ID: 3928801
[TBL] [Abstract][Full Text] [Related]
19. Hereditary tyrosinemia type I. Self-induced correction of the fumarylacetoacetase defect.
Kvittingen EA; Rootwelt H; Brandtzaeg P; Bergan A; Berger R
J Clin Invest; 1993 Apr; 91(4):1816-21. PubMed ID: 8473520
[TBL] [Abstract][Full Text] [Related]
20. Hereditary tyrosinemia type I--an overview.
Kvittingen EA
Scand J Clin Lab Invest Suppl; 1986; 184():27-34. PubMed ID: 3296130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
